Beyond Air (Nasdaq: XAIR) is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors.

This fireside chat was recorded during the Lytham Partners 2026 Investor Healthcare Summit.